Source: Korea Biomedical Review

Access Bio: Access Bio's legal victory overturned, case against Gredale reopened in Covid diagnostics kit dispute

Access Bio, the Kosdaq-listed in-vitro diagnostics company based in New Jersey that profited from selling Covid-19 testing kits, has had its legal victory overturned by a New Jersey court. The court's decision to invalidate a previous ruling in favor of Access Bio has reignited the case against Cali

Read full article »
Annual Revenue
$25-100M
Employees
25-100
Young H. Choi's photo - President & CEO of Access Bio

President & CEO

Young H. Choi

CEO Approval Rating

85/100

Read more